Skip to content

Diagnostic accuracy of photon-counting detector CT for detection of coronary in-stent restenosis.

Sep 2026 · Cardiovascular Revascularization Medicine · 0 citations · 19 references
Medicine

Abstract

Background

Photon-counting detector computed tomography (PCD-CT) offers improved spatial resolution and reduced blooming artifacts compared with conventional CT, potentially improving visualization of coronary stents. We evaluated the diagnostic performance of PCD-CT for detecting significant coronary in-stent restenosis (ISR) using invasive coronary angiography (ICA) as the reference standard.

Methods

This retrospective, single-center diagnostic-accuracy study included consecutive adults with prior coronary stenting who underwent clinically indicated PCD-CT followed by ICA between February 2025 and January 2026. The primary outcome was the diagnostic performance of PCD-CT for detecting significant ISR, defined as >50% luminal diameter stenosis, on a per-stent basis. Secondary analyses evaluated patient-level performance and exploratory differences according to stent diameter, length, and location.

Results

The study included 52 patients (mean age, 70.5 ± 9.7 years; 83% male) with 69 evaluated stents. Significant ISR was present on ICA in 16 stents. PCD-CT correctly identified 12 of 16 stents with ISR and excluded ISR in 44 of 53 stents without ISR, corresponding to a sensitivity of 75.0%, specificity of 83.0%, positive predictive value of 57.1%, negative predictive value of 91.7%, and area under the curve (AUC) of 0.79 (95% CI, 0.67-0.91). Patient-level sensitivity was 86.7%, specificity was 85.7%, and AUC was 0.86 (95% CI, 0.76-0.97). Diagnostic performance was numerically higher in stents ≥3 mm than in stents <3 mm (AUC, 0.82 versus 0.71), although the difference was not statistically significant (P = 0.42).

Conclusion

PCD-CT demonstrated promising diagnostic performance and a high negative predictive value for detecting significant coronary ISR. Its potential utility for excluding ISR, including in smaller stents, warrants validation in larger prospective multicenter studies using standardized acquisition protocols.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.